Navigating the Future: Life Science Instrumentation Market Trends and Forecast Insights, 2025 Edition

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Life Science Instrumentation Market Size Growth Forecast: What to Expect by 2025?
In recent times, the life science instrumentation market has experienced robust growth. It is projected to escalate from $66.22 billion in 2024 to $70.86 billion in 2025, registering a compound annual growth rate (CAGR) of 7.0%. Factors contributing to this growth in the past include the advent of personalized medicine, biotechnology sector expansion, government subsidies and grants, newly emerging diseases and health risks, and an increase in the elderly population and chronic illnesses.

How Will the Life Science Instrumentation Market Size Evolve and Grow by 2029?
A robust growth is anticipated in the life science instrumentation market in the upcoming years, with its size projected to spike to $91.9 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.7%. The rise during the predicted period could be associated with research on environmental and climate change, increased funding from both government and private sectors, regulatory adherence, the emergence of infectious illnesses, and widening use in the sectors of food and agriculture. The forecast period is expected to see key trends such as advancements in the field of genomics, the incorporation of AI and machine learning, miniaturization and portability, automation and robotic technology, as well as increased reliance on digital and cloud-based solutions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/life-science-instrumentation-global-market-report

What Drivers Are Propelling the Growth of Life Science Instrumentation Market Forward?
An upsurge in the number of genetic disorders is anticipated to boost the expansion of the life science instrumentation market in the future. Genetic disorders, defined as diseases or conditions triggered by irregularities in a person's DNA or chromosomes, are on the rise due to improvements in diagnostic technologies, heightened awareness, and alterations in reproductive habits. Life science devices are used by individuals with genetic disorders for diagnosis, tracking, and creating personalized treatments through the examination of genetic substances and biomarkers. For instance, Alzheimer Society, a UK-based charity that focuses on dementia care and research, found that around 982,000 individuals were living with dementia in the UK in May 2023 and this figure is projected to go up to 1.4 million by 2040. Hence, the escalating prevalence of genetic disorders is enhancing the growth of the life science instrumentation market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19545&type=smp

Which Emerging Trends Are Transforming the Life Science Instrumentation Market in 2025?
In the life science instrumentation market, dominant corporations are keen on creating novel solutions, like state-of-the-art milling technology, that bolster exactness and productivity in sample synthesis and examination. Milling technology encompasses advanced methodologies and machinery that enables high accuracy and productivity in the physical manipulation of substances, especially in the preparation of samples for life science studies. For instance, Thermo Fisher Scientific Inc., a firm from the United States specializing in life science and clinical research, in August 2022, unveiled the Arctis Cryo-Plasma Focused Ion Beam (Cryo-PFIB), an innovative, automated microscope purposed to markedly improve cryo-electron tomography research. This avant-garde system comes with an autoloader capable of accommodating up to 12 grids, enabling robotic operation which minimizes contamination hazards and heightens the effectiveness of sample processing. It also incorporates an integrated fluorescence microscope (iFLM) that lets researchers study samples concurrently using light, ion, or electron beams, thereby ensuring accurate targeting and verification of regions prior to and during the milling operation.

What Are the Key Segments in the Life Science Instrumentation Market?
The life science instrumentationmarket covered in this report is segmented -

1) By Technology: Spectroscopy, Chromatography, Polymerase Chain Reaction, Immunoassays, Lyophilization, Liquid Handling, Clinical Chemistry Analyzers, Microscopy, Flow Cytometry, Other Technologies
2) By Application: Research Applications, Clinical And Diagnostic Applications, Other Applications
3) By End User: Hospitals And Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Agriculture And Food Industries, Environmental Testing Labs, Clinical Research Organizations, Other End-Users

Subsegments:
1) By Spectroscopy: UV-Vis Spectroscopy, Infrared Spectroscopy (IR), Mass Spectrometry, Nuclear Magnetic Resonance (NMR) Spectroscopy, Raman Spectroscopy
2) By Chromatography: Gas Chromatography (GC), High-Performance Liquid Chromatography (HPLC), Thin Layer Chromatography (TLC), Ion Chromatography (IC), Supercritical Fluid Chromatography (SFC)
3) By Polymerase Chain Reaction (PCR): Quantitative PCR (qPCR), Reverse Transcription PCR (RT-PCR), Digital PCR, Multiplex PCR
4) By Immunoassays: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Chemiluminescent Immunoassay (CLIA), Lateral Flow Immunoassay, Western Blotting
5) By Lyophilization: Freeze Drying Equipment, Lyophilization Monitoring Systems, Freeze-Dried Storage Systems
6) By Liquid Handling: Automated Liquid Handling Systems, Manual Pipettin*g Systems, Microplate Readers and Washers, Liquid Handling Robotics

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19545&type=smp

Who Are the Key Players Shaping the Life Science Instrumentation Market's Competitive Landscape?
Major companies operating in the life science instrumentation market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE HealthCare Technologies Inc., Agilent Technologies Inc., Hitachi High-Technologies Corporation, Nikon Corporation, bioMérieux S.A., Shimadzu Corporation, PerkinElmer Inc., Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Horiba Ltd., Eppendorf AG, Tecan Trading AG, JEOL Ltd., Leica Microsystems, Cytek Biosciences Inc., Sigma Laborzentrifugen GmbH

What Geographic Markets Are Powering Growth in the Life Science Instrumentation Market?
North America was the largest region in the life science instrumentation market in 2024. The regions covered in the life science instrumentation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19545

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.